Study finds most people trust doctors more than AI but see its potential for cancer diagnosis
Nationally representative surveys measure public attitudes toward AI in healthcare
2025-12-08
(Press-News.org) FOR IMMEDIATE RELEASE
EMBARGOED UNTIL DECEMBER 8, 2025
Study Finds Most People Trust Doctors More than AI But See Its Potential for Cancer Diagnosis
Nationally representative surveys measure public attitudes toward AI in healthcare
Washington, D.C., December 8, 2025– New research on public attitudes toward AI indicates that most people are reluctant to let ChatGPT and other AI tools diagnose their health condition, but see promise in technologies that use AI to help diagnose cancer. These and other results of two nationally representative surveys will be presented at the annual meeting of the Society for Risk Analysis Dec. 7-10 in Washington, DC.
Led by behavioral scientist Dr. Michael Sobolev of the Schaeffer Institute for Public Policy & Government Service at the University of Southern California, and psychologist Dr. Patrycja Sleboda, assistant professor at Baruch College, City University of New York, the study focuses on public perspectives—specifically trust, understanding, potential, excitement, and fear of AI—in the context of cancer diagnosis, one of AI’s most commonly used and impactful applications in medicine. It also examines how these public attitudes vary by demographics, such as age, gender and education.
The study used data from two nationally representative surveys to assess how personal use of AI tools like ChatGPT and general trust in medical AI relate to the acceptance of an AI-based diagnostic tool for cervical cancer.
Key findings:
Most people still trust doctors more than AI. Only about 1 in 6 people (17%) said they trust AI as much as a human expert to diagnose health problems.
People who have tried AI (like ChatGPT) feel more positive about AI’s application in medicine. Those who had used AI in their personal life said they understood it better and were more excited and trusting of its use in healthcare. (55.1% of respondents had heard of ChatGPT but not used it, while 20.9% had both heard of and used it.)
People see promise, not danger. When participants learned about an AI tool that helps find early signs of cancer, most thought it had great potential and were more excited than afraid.
“Our research shows that even a little exposure to AI—just hearing about it or trying it out—can make people more comfortable and trusting of the technology. We know from research that familiarity plays a big role in how people accept new technologies, not just AI,” says Sleboda.
In the first survey, participants reported whether they had heard of or used AI technologies and responded to questions about their general trust in AI for health diagnoses.
In the second survey, participants were introduced to a scenario based on real development in which a research team developed an AI system that can analyze digital images of the cervix to detect precancerous changes (a technology called automated visual evaluation). Participants then rated on a scale (from 1 to 5) five elements of acceptance for this diagnostic AI tool: understanding, trust, excitement, fear and potential.
An analysis of the results showed that potential was rated the highest when judging a diagnostic AI tool, followed by excitement, trust, understanding and fear. Identifying as male and having a college degree were associated with greater trust, excitement and potential for the use of AI in healthcare. These participants also expressed lower fear of the use of AI overall.
“We were surprised by the gap between what people said in general about AI and how they felt in a real example” says Sobolev, who leads the Behavioral Design Unit at Cedars-Sinai Medical Center in Los Angeles, with the goal of advancing human-centered innovation. “Our results show that learning about specific, real-world examples can help build trust between people and AI in medicine.”
###
EDITORS NOTE:
This research will be presented on December 8 at 3:30 EST at the Society for Risk Analysis (SRA) Annual Conference at the Downtown Westin Hotel in Washington, D.C. SRA Annual Conference welcomes press attendance. Please contact Emma Scott at emma@bigvoicecomm.com to register.
About Society for Risk Analysis
The Society for Risk Analysis (SRA) is a multidisciplinary, global organization dedicated to advancing the science and practice of risk analysis. Founded in 1980, SRA brings together researchers, practitioners, and policymakers from diverse fields including engineering, public health, environmental science, economics, and decision theory. The Society fosters collaboration and communication on risk assessment, management, and communication to inform decision-making and protect public well-being. SRA supports a wide range of scholarly activities, publications, and conferences. Learn more at www.sra.org.
Media Contact:
Emma Scott
Media Relations Specialist
Emma@bigvoicecomm.com
(740) 632-0965
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-12-08
Embargoed for release: Monday, December 8, 2025, 4:00 PM ET
Key points:
Children whose schools reopened during the COVID-19 pandemic had significantly decreased mental health diagnoses relative to children whose schools remained closed, according to a new study of schools across California. This included fewer diagnoses of depression, anxiety, and ADHD. Girls’ mental health benefited the most.
Mental health care spending decreased by up to 11% by the ninth month after a school’s reopening.
The study is among the largest and most data-rich examinations of how school closures impacted ...
2025-12-08
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego scientists and an international team of researchers have identified several promising molecules that could lead to new medications capable of combating these resistant variants.
Instead of looking for antiviral candidates from scratch, the research team screened 141 previously synthesized compounds that had originally been designed between 1997 and 2012 to inhibit a key enzyme called cruzain. ...
2025-12-08
Reston, VA (December 8, 2025) As nuclear medicine theranostics expands rapidly across clinical practice worldwide, a new supplement to the Journal of Nuclear Medicine Technology (JNMT) explores how nuclear medicine technologists are embracing their growing role within the field. Titled, Building the Future of Theranostics: Advancing Practice, Education, and Innovation Worldwide, the supplement brings together voices from across the globe, offering perspectives that span clinical lessons, educational frameworks, operational strategies, advocacy, equity, and biology.
From the early use of ...
2025-12-08
Hoboken, N.J., December 8, 2025 — On Saturday December 6, 2025 Alaska was rocked by a 7.0 magnitude quake. Though not always so forceful, earthquakes happen every day. On average, about 55 of them strike daily, according to the United States Geological Survey (USGS), totaling some 20,000 annually worldwide. About once a year, one reaches 8.0 points or greater and 15 others hit within the magnitude 7 range on the Richter scale, which measures earthquakes by the energy they release. For example, in just 2025 an 8.8 earthquake offshore from the Kamchatka Peninsula in Russia, ...
2025-12-08
MIAMI, FLORIDA (EMBARGOED UNTIL DEC. 8, 2025, AT 2:45 P.M. EST) – Most patients with a rare and aggressive form of large B-cell lymphoma can safely receive a less toxic treatment than the intensive chemotherapy often used, according to new research from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.
Lead researcher Juan Alderuccio, M.D., a hematologist and lymphoma specialist at Sylvester, will present this research Dec. 8 at the American Society of Hematology ...
2025-12-08
The sense of smell is vital for animals, as it helps them find food, protect themselves from predators and interact socially. An international research team led by Dr Quentin Martinez and Dr Eli Amson from State Museum of Natural History Stuttgart has now discovered that certain areas of the brain skull allow conclusions to be drawn about the sense of smell in mammals. Particularly significant is the volume of the endocast of the olfactory bulb, a bony structure in the skull that is often well preserved even in very old fossils. This volume is closely related to the number of intact odour receptor genes – an important ...
2025-12-08
One of the most important steps in the evolution of modern mammals was the development of highly sensitive hearing. The middle ear of mammals, with an eardrum and several small bones, allows us to hear a broad range of frequencies and volumes, which was a big help to early, mostly nocturnal mammal ancestors as they tried to survive alongside dinosaurs.
New research by paleontologists from the University of Chicago shows that this modern mode of hearing evolved much earlier than previously thought. Working with detailed CT scans of the skull and jawbones of Thrinaxodon liorhinus, a 250-million-year-old mammal predecessor, they used engineering methods to simulate ...
2025-12-08
The negative health impacts from contamination by so called "forever chemicals" in drinking water costs the contiguous U.S. at least $8 billion a year in social costs, a University of Arizona-led study has found.
The study, published in the Proceedings of the National Academy of Sciences, builds on previous research into how PFAS – per- and polyfluoroalkyl substances – can negatively impact health when the chemicals contaminate drinking water. The research team studied all births in New Hampshire from 2010-2019, focusing on mothers living ...
2025-12-08
A new advance from Carnegie Mellon University researchers could reshape how clinicians identify the brain regions responsible for drug-resistant epilepsy. Surgery can be a life-changing option for millions of epilepsy patients worldwide, but only if physicians can accurately locate the epileptogenic zone, the area where seizures originate.
Bin He, professor of biomedical engineering, and his team have developed a unified, machine learning-based approach called spatial-temporal-spectral imaging (STSI) to assist. It is the first technology capable of analyzing every major type of epileptic ...
2025-12-08
Irvine, Calif., Dec. 8, 2025 — With a $50 million lead gift from the Quilter family and approximately $30 million in new commitments, the University of California, Irvine’s Institute for Memory Impairments and Neurological Disorders will begin planning to build a state-of-the-art research and care facility to enhance its position as a global leader in Alzheimer’s disease and related dementias research and patient care.
UC Irvine alumni Charles Quilter, M.A. ’06, Ph.D. ’10, and Ann Quilter, M.S. ’79, and their family members Patrick, Chris, Matt and Patty made the generous contribution ...
LAST 30 PRESS RELEASES:
[Press-News.org] Study finds most people trust doctors more than AI but see its potential for cancer diagnosis
Nationally representative surveys measure public attitudes toward AI in healthcare